These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12591534)

  • 21. Perioperative administration of FTY720 and CTLA4IG in rat heart transplantation.
    Ohba M; Li XK; Kita Y; Tamura A; Enosawa S; Sasakuri S; Ogoshi S; Amemiya H; Suzuki S
    Transplant Proc; 2000 Nov; 32(7):2024-5. PubMed ID: 11120049
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction of lymphocyte apoptosis and prolongation of allograft survival by FTY720.
    Suzuki S; Li XK; Shinomiya T; Enosawa S; Kakefuda T; Mitsusada M; Amemiya H; Takahara S; Amari M; Naoe S; Hoshino Y; Chiba K
    Transplant Proc; 1996 Aug; 28(4):2049-50. PubMed ID: 8769151
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunosuppressive action of FTY720 for renal allograft a rat model.
    Kunikata S; Nagano T; Nishioka T; Akiyama T; Kurita T
    Transplant Proc; 1999; 31(1-2):1157-9. PubMed ID: 10083517
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell cycle arrest effects of large-dose FTY720 on lymphocytes in mouse skin transplantation models.
    Li QY; Chi YY; Liu SQ
    Immunopharmacol Immunotoxicol; 2008; 30(2):365-81. PubMed ID: 18569090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial immunosuppressive effect of FTY720 combined with intrathymic injection of splenic cells on rat pancreaticoduodenal allograft.
    Suzuki K; Kazui T; Kawabe A; Li XK; Amemiya H; Suzuki S
    Transplant Proc; 1998 Jun; 30(4):1067-8. PubMed ID: 9636432
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolongation of concordant xenograft survival by a newly developed drug, FTY720.
    Fujiwara I; Nakajima H; Matsuda T; Mizuta N; Yamagishi H; Oka T
    Transplant Proc; 1999 Nov; 31(7):2831-3. PubMed ID: 10578306
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new immunosuppressant, FTY720, prolongs limb allograft survival in rats.
    Muramatsu K; Doi K; Shigetomi M; Kido K; Kawai S
    Ann Plast Surg; 1998 Feb; 40(2):160-5. PubMed ID: 9495465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
    Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
    Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FTY720: a new immunosuppressive agent with novel mechanism(s) of action.
    Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2210-3. PubMed ID: 9723444
    [No Abstract]   [Full Text] [Related]  

  • 33. Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model.
    Suzuki T; Shimamura T; Jin MB; Yokota R; Fukai M; Iida J; Taniguchi M; Magata S; Horiuchi H; Yamashita K; Nomura M; Omura T; Kishida A; Furukawa H; Todo S
    Transplant Proc; 1999; 31(1-2):1208-9. PubMed ID: 10083540
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.
    Suzuki S; Enosawa S; Kakefuda T; Amemiya H; Hoshino Y; Chiba K
    Transplant Proc; 1996 Jun; 28(3):1375-6. PubMed ID: 8658701
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.
    Liu L; Wang C; He X; Shang W; Bi Y; Wang D
    Microsurgery; 2007; 27(4):300-4. PubMed ID: 17477424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FTY720: altered lymphocyte traffic results in allograft protection.
    Brinkmann V; Pinschewer DD; Feng L; Chen S
    Transplantation; 2001 Sep; 72(5):764-9. PubMed ID: 11571432
    [No Abstract]   [Full Text] [Related]  

  • 37. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH; Milekhin V; Zhang H; Huang HZ
    Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
    Yuzawa K; Stephkowski SM; Wang M; Kahan BD
    Transplant Proc; 2000 Mar; 32(2):269. PubMed ID: 10715413
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of long-term administration of low-dose FTY720 on survival of murine cardiac allograft.
    Cheng Q; Li D; Liang H; Yang H; Lei D; Gao D; Long X; Chen Y; Zhu P; Chen X
    J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):199-204. PubMed ID: 22528220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival.
    Yanagawa Y; Hoshino Y; Chiba K
    Int J Immunopharmacol; 2000 Aug; 22(8):597-602. PubMed ID: 10988354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.